The mammalian placenta is remarkably distinct between species, suggesting a history of rapid evolutionary diversification 1 . To gain insight into the molecular drivers of placental evolution, we compared biochemically predicted enhancers in mouse and rat trophoblast stem cells (TSCs) and found that species-specific enhancers are highly enriched for endogenous retroviruses (ERVs) on a genome-wide level. One of these ERV families, RLTR13D5, contributes hundreds of mouse-specific histone H3 lysine 4 monomethylation (H3K4me1)- and histone H3 lysine 27 acetylation (H3K27ac)-defined enhancers that functionally bind Cdx2, Eomes and Elf5-core factors that define the TSC regulatory network. Furthermore, we show that RLTR13D5 is capable of driving gene expression in rat placental cells. Analysis in other tissues shows that species-specific ERV enhancer activity is generally restricted to hypomethylated tissues, suggesting that tissues permissive for ERV activity gain access to an otherwise silenced source of regulatory variation. Overall, our results implicate ERV enhancer co-option as a mechanism underlying the extensive evolutionary diversification of placental development.
The mammalian placenta is remarkably distinct between species, suggesting a history of rapid evolutionary diversification 1 . To gain insight into the molecular drivers of placental evolution, we compared biochemically predicted enhancers in mouse and rat trophoblast stem cells (TSCs) and found that species-specific enhancers are highly enriched for endogenous retroviruses (ERVs) on a genome-wide level. One of these ERV families, RLTR13D5, contributes hundreds of mouse-specific histone H3 lysine 4 monomethylation (H3K4me1)- and histone H3 lysine 27 acetylation (H3K27ac)-defined enhancers that functionally bind Cdx2, Eomes and Elf5-core factors that define the TSC regulatory network. Furthermore, we show that RLTR13D5 is capable of driving gene expression in rat placental cells. Analysis in other tissues shows that species-specific ERV enhancer activity is generally restricted to hypomethylated tissues, suggesting that tissues permissive for ERV activity gain access to an otherwise silenced source of regulatory variation. Overall, our results implicate ERV enhancer co-option as a mechanism underlying the extensive evolutionary diversification of placental development.
During pregnancy, maternal-fetal physiological exchange is mediated by the placenta, an organ that emerged in mammals 150 million years ago. Although the placenta performs the same basic function in all mammals, pronounced interspecies differences exist in overall structure, organization of tissue layers and trophoblast cell types 1 . The marked evolutionary diversification of the placenta is thought to be driven in part by parent-offspring conflict, where disagreement over optimal parental investment leads to antagonistic coevolution at the placental interface [2] [3] [4] . Evidence suggests that regulatory mutations may underlie the morphological diversification of the placenta, as the development of the placenta is governed by highly conserved proteins 5, 6 . Although many placenta-specific proteins are rapidly evolving, these are primarily hormones and growth factors secreted during the later physiological response to pregnancy and are not expressed during placental development [7] [8] [9] . Overall, this suggests that regulatory mutations-rather than protein-coding mutations-may form the basis for placental morphological evolution.
As mounting evidence has implicated regulatory mutations as a general mechanism underlying developmental diversification 10 , we sought to investigate the regulatory landscape of early placental development in two closely related species-mouse and rat. Despite the similarities between mouse and rat placentation, genes expressed by the mature placenta show clear signs of rapid evolution since rodents diverged 9 , suggesting that evolution at the regulatory level may also be detected. We cultured mouse and rat TSCs, which represent the first cell population to give rise to the fetal placenta 11 , and performed 3′-end RNA sequencing (3′ RNA-seq) 12 and chromatin immunoprecipitation with sequencing (ChIP-seq) for histone marks indicative of promoters (trimethylation of histone H3 at lysine 4 (H3K4me3)), enhancers (H3K4me1 and H3K27ac) and repressed regions (trimethylation at histone H3 lysine 27 (H3K27me3) and trimethylation at histone H3 lysine 9 (H3K9me3)) 13 . Only high-quality, uniquely mapping reads were retained, and histone-marked regions were identified using MACS (v2.09) with false discovery rate (FDR) < 0.05. We predicted 9,460 mouse and 7,932 rat TSC promoters on the basis of H3K4me3 enrichment over gene transcriptional start sites (TSSs), which were associated with expressed genes (Fig. 1a,b) . We predicted 52,476 mouse and 41,142 rat TSC enhancers on the basis of distal enrichment of H3K4me1 (>5 kb from a gene TSS) and 25,736 mouse and 4,471 rat regions of distal H3K27ac enrichment. These predicted enhancers were significantly enriched near genes with annotated placental function (P = 1 × 10 −51 , binomial test; Supplementary Fig. 1 ). Repressive marks H3K9me3 and H3K27me3 were predominantly intergenic, consistent with their association with inactive chromatin (Fig. 1b) . Notably, we did not observe H3K27me3 at promoters in either species (Fig. 1a,b and Supplementary Fig. 2a,b) , suggesting that H3K27me3 does not associate with silenced promoters within the placenta. These observations are consistent with a previous study 14 and, together, strongly suggest that Polycomb activity in TSCs is distinct from its role in embryonic stem cells (ESCs) and that trophoblast-specific mechanisms of gene repression are likely to be conserved across rodents.
If regulatory mutations drive morphological differences between mouse and rat, then identifying species-specific regulatory elements might identify genomic regions that underlie species-specific features of placentation. To this end, we compared the regulatory landscapes in these species by mapping each regulatory element from rat to its orthologous position in the mouse genome, and we then examined whether the chromatin state at each region was epigenetically conserved l e t t e r s (Fig. 2a) . We found that, although the majority of promoter regions were conserved between mouse and rat, both enhancer and repressed regions were predominantly species specific. Notably, 8-10% of speciesspecific enhancers could not be mapped to the other genome. We found that over 80% of these unmappable enhancers directly overlapped with species-specific transposable elements (TEs). TEs have been established as important mediators of regulatory evolution because of their intrinsic regulatory activity 15 , and species-specific TEs constitute the majority of genomic DNA unique to the mouse or rat genome 16 . Taken together, these analyses indicate that the TSC regulatory landscape has undergone substantial evolution since the divergence of rodents and identify TEs as an important source of this variation.
As TEs have been implicated in the regulatory evolution of other systems 17 , we next investigated whether specific families of TEs have contributed to rapid evolutionary amplifications of enhancers, promoters or repressed regions within TSCs. Therefore, we identified TEs whose individual copies were significantly overrepresented within each set of regulatory elements, using a conservative binomial test to compare the observed overlap against background expectation (Fig. 2b 
Figure 2
Comparison of mouse and rat shows overabundance of species-specific ERVs in enhancer regions. (a) Rat TSC ChIPseq-defined regulatory elements were mapped to their orthologous positions in the mouse genome. If the same histone mark was present in mouse, then the element was considered epigenetically conserved. Non-conserved elements were further distinguished by whether the genomic DNA was mappable to the other genome or derived from species-specific sequence. Each category is represented as a fraction of the total number of elements in the ChIP-seq data set. In both species, the unmappable regions were predominantly composed of species-specific TEs. (b) We identified TE families whose copies were overrepresented within a set of regulatory elements. For each family, the number of individual copies observed residing within a set of regulatory elements is plotted against the random expectation. Significantly overrepresented families (Bonferroni P < 0.005) are indicated in blue. (c) Overrepresented mouse TE families from b plotted against the average fraction of nucleotide divergence of their individual copies compared to the consensus sequence, which is a proxy for the evolutionary age of the TE. Each data point is colored according to TE class. Divergence measurements representing the distance between mouse and rat or mouse and human are depicted by the dashed lines. SINE, short interspersed element.
npg l e t t e r s enrichment of TEs, consistent with the high overall conservation of promoters observed between mouse and rat. Unexpectedly, we found multiple species-specific ERVs enriched in both mouse and rat TSC enhancer regions (marked by both H3K4me1 and H3K27ac or by either alone) ( Fig. 2c and Supplementary Fig. 3 ). These observations suggest that the amplification of specific TE families might have shaped enhancer activity during placental evolution. The enrichment of species-specific ERV families within predicted TSC enhancer regions prompted us to investigate ERVs as potential drivers of placental regulatory evolution. For this analysis, we selected one mouse-specific ERV, RLTR13D5, which was highly enriched within mouse TSC enhancer regions defined by both H3K4me1 and H3K27ac marks. RLTR13D5 is present in 608 copies that have ~91% sequence identity to their consensus sequence, indicating that this element likely integrated into the mouse genome 15-25 million years ago but no longer actively replicates (Fig. 3a) . Of the 608 copies, 95 showed enrichment of both H3K4me1 and H3K27ac in the absence of H3K9me3 compared to the <20 expected by chance (Fig. 3b,c) . The strong association between RLTR13D5 copies and enhancer marks prompted us to ask whether the RLTR13D5 consensus sequence harbored transcription factor binding motifs that might drive enhancer function. Notably, statistically significant binding sites (P < 1 × 10 −5 ) were predicted for Eomes, Cdx2 and Elf5 (Fig. 3d) , which together are known to define the core TSC regulatory network [18] [19] [20] . Furthermore, although individual RLTR13D5 copies showed 9% nucleotide divergence on average, the majority of copies retained these binding motifs ( Supplementary Fig. 4) . These results suggest that RLTR13D5 copies may serve as mouse-specific enhancer elements by recruiting the core TSC regulatory machinery.
Although the presence of binding motifs is suggestive of function, we next tested whether Eomes, Cdx2 and Elf5 physically associate with RLTR13D5 and other ERVs. To this end, we performed ChIPseq with antibodies to Eomes, Cdx2 and Elf5 in mouse TSCs, using 100-bp paired-end reads to assist in detecting punctuate binding sites within repetitive regions. We identified thousands of binding sites for Eomes (45,730), Cdx2 (11, 451) and Elf5 (34,751), and de novo motif discovery recovered the canonical motifs for each transcription factor (Figs. 3d and 4a) . All three transcription factors showed npg l e t t e r s significant association with RLTR13D5 (Eomes Bonferroni P = 2.8 × 10 −107 , Cdx2 P = 2.5 × 10 −136 , Elf5 P = 1.8 × 10 −227 , binomial test) (Fig. 4b) . Examination of the transcription factor and histone occupancy across all RLTR13D5 copies identified strong patterns of co-occupancy at a subset of copies with potential enhancer activity (Fig. 4c) , as well as a clear bimodal distribution of H3K4me1 and H3K27ac marks, with all transcription factor binding centered between the histone peaks-a configuration strongly associated with active enhancers (Fig. 4d) 21 . Notably, 40% (241) of all RLTR13D5 copies were bound by at least 1 transcription factor, and 16% (96) were bound by all 3-Eomes, Cdx2 and Elf5. As regions containing multiple transcription factor binding sites are most likely to function as active enhancers 22 , we next examined how frequently the simultaneous association of all three transcription factors occurred across the genome and, subsequently, what portion of these regions were derived from ERVs. We found a total of 945 triply bound regions across the genome, 96 (10%) of which were derived from RLTR13D5. Notably, in addition to RLTR13D5, several closely related ERVs, including RLTR13B4 and RLTR13C3, were also markedly enriched at triply bound regions (Fig. 4b) . Overall, we found that 35% (336) of all genomic regions triply bound by Eomes, Cdx2 and Elf5 were derived directly from the mouse-specific RLTR13 ERV superfamily, demonstrating their central role in substantially reshaping the TSC core regulatory network. As RLTR13 elements have all the hallmarks of active TSC enhancers, we next investigated whether these elements functionally influence placental gene expression. First, given that RLTR13 is mouse specific, we asked whether genes proximal to RLTR13-derived enhancers show species-specific patterns of expression. From our 3′ RNA-seq data, we identified 9,698 orthologous genes that had TSC expression in either rat or mouse or in both. We then determined which of these genes were proximal to the 336 triply bound RLTR13 elements within a range of 100 kb. This analysis yielded 114 genes that showed increased expression in mouse relative to rat (P = 0.0036, Wilcoxon signed-rank test), consistent with RLTR13 elements enhancing proximal gene expression in a species-specific manner (Fig. 5a ). Next, we tested whether RLTR13-derived enhancers could functionally drive gene expression by performing a luciferase assay in Rcho-1 cells 23 , a readily transfectable rat TSC model with no native RLTR13 elements in its genome. We selected two copies of RLTR13D5 for examination. The first was an 'active' copy with H3K27ac and H3K4me1 marks that was bound by Cdx2, Eomes and Elf5 and was adjacent to Apoceb3, which is expressed in mouse TSCs but not in rat. The second was a 'decayed' copy that harbored a 200-bp deletion that removed the binding sites for Cdx2, Eomes and Elf5 (Fig. 5b) . We found that the active copy drove a significant, twofold increase in expression over that from the minimal promoter, whereas the decayed copy was unable to drive expression (Fig. 5c) . Overall, these results show that RLTR13D5 is capable of driving gene expression in placental cells and provide strong evidence that RLTR13-derived enhancers have facilitated the evolution of mousespecific gene expression patterns in TSCs.
We next asked whether species-specific ERVs might function as enhancer elements in other tissues. Using the mouse Encyclopedia of DNA Elements (ENCODE) H3K4me1 data sets 24 , we identified putative regulatory TEs in 11 non-placental tissues. First, we found that RLTR13D5 and the majority of other putative ERV enhancers predicted from our TSC data set were not enriched within the enhancer b c npg l e t t e r s regions of other tissues, indicating that their activity is restricted to the placenta (Fig. 6a) . We next found that, whereas putative regulatory TEs could be identified in most tissues, most of these TEs were ancient (shared in mouse, rat and human) and constituted multiple classes, including DNA transposons (Fig. 6b) . This is in contrast to TSCs, where the majority of regulatory TEs are species-specific ERVs. ESCs and testis were the only other samples in which speciesspecific ERVs showed putative regulatory activity. Notably, placenta, ESCs and testis all feature global DNA hypomethylation and intrinsic ERV activity. This is in stark contrast to the embryo proper, which undergoes genome-wide methylation and silences retroviral activity [25] [26] [27] . Overall, this suggests the correlation between a permissive epigenetic state and the ability of ERVs to escape repression. Escape from repression within these few cellular contexts, most notably, the placenta, may allow for ERVs to function as active enhancers, potentially altering the development of these tissues.
We suggest that species-specific ERVs contribute to the rapid divergence of the placental gene regulatory network. ERVs have affected diverse aspects of mammalian biology 17, 28, 29 and have been influential in shaping placental evolution by contributing viral proteins that mediate placental growth, immunosuppression and cell fusion 30 . ERVs are normally repressed by the embryo, but, for reasons that remain unclear, ERVs are highly active in the mammalian placenta 31 . Our findings suggest a model in which placental ERV activity may be adaptive over time. Under parent-offspring conflict theory, the placental interface is shaped by ongoing conflict between mother and fetus 4 . We speculate that ERV variation, exposed by the permissive epigenetic state within the placenta, allows the fetus increased evolvability against maternal defenses. Specifically, by relaxing epigenetic repression of ERV activity, the placenta gains access to a highly polymorphic source of enhancer elements that may directly influence its developmental phenotype ( Supplementary  Fig. 5 ). As the placenta is a transient organ, the long-term advantage conferred by increased developmental evolvability would outweigh the potentially mutagenic effects of ERV activity. We propose this model as a plausible explanation for the persistence of placentaspecific ERV activity, which has been observed in all major mammalian taxa 31 . Our study shows that ERVs facilitate placental evolution at the regulatory level by serving as active developmental enhancers and that this mechanism-made possible by the unique epigenetic environment of trophoblast cells-may contribute to the extensive morphological diversification of the placenta.
URLs. RepeatMasker, http://www.repeatmasker.org/.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. All 3′ RNA-seq and ChIP-seq data for both mouse and rat have been deposited at the Gene Expression Omnibus (GEO) under accession GSE42207.
ONLINE METHODS
TSC culture. Mouse TSCs were obtained from J. Rossant and maintained in DMEM/F12 with 15 mM HEPES, 20% FBS, 2 mM glutamine, 100 µg/ml streptomycin, 1 mM sodium pyruvate and 100 µM β-mercaptoethanol supplemented with activin, fibroblast growth factor 4 (FGF4) and heparin as previously described 32 . Rat TSCs and Rcho-1 TSCs were cultured as previously described 23, 33 .
ChIP-seq assays. Each ChIP assay was performed with 20 million cells (100 million for transcription factors) using the ChIP Assay kit (Millipore) following the manufacturer's instructions. Briefly, cells were cross-linked in 2% formaldehyde for 15 min, the cross-linking reaction was quenched in 1 M glycine for 5 min and cells were washed twice with PBS, resuspended in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1) supplemented with a protease inhibitor cocktail (Roche) and incubated for 30 min. Cell lysates were diluted 1:1 with dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl) and then sonicated for 12 cycles (30 s on/off) at 60% amplitude to produce an average fragment size range of 300-600 bp. Immunoprecipitation was performed by incubation with 2-5 µg of antibody (H3K4me3: ActiveMotif, 39159; H3K27me3: ActiveMotif, 39535; H3K27ac: Abcam, ab4729; H3K9me3: Abcam, ab8898; H3K4me1: Abcam, ab8895; CDX2: Bethyl Labs, A300-691-A; EOMES: Abcam, ab23345; ELF5: Santa Cruz Biotechnology, sc-9645x) conjugated to 50 µl of protein G Dynabeads (Invitrogen) overnight. Bead-chromatin complexes were washed using high-salt immune complex wash (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 500 mM NaCl), low-salt immune complex wash (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), LiCl immune complex wash (0.25 M LiCl, 1% IGEPAL, 1% deoxycholate acid, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1) and TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0), with each wash performed twice for 5 min. Cell lysis, sonication, immunoprecipitation and cleanup steps were all performed at 4 °C. Finally, chromatin was eluted from beads using elution buffer (1% SDS, 0.1M NaHCO 3 ), protein-DNA cross-links were reversed with the addition of 5 M NaCl and DNA was purified using QIAquick column cleanup (Qiagen). Immunoprecipitated DNA (50-500 ng) was prepared for sequencing using the Illumina genomic DNA preparation kit. Briefly, DNA fragments were end repaired and ligated to Illumina adaptor linkers, size selected using Invitrogen E-gel SizeSelect agarose gels (Invitrogen), PCR amplified for 15 cycles (18 for transcription factors) and purified using AMPure XP beads (Beckman Coulter). Libraries were sequenced using the Illumina Genome Analyzer IIx or HiSeq 2000.
ChIP-seq analysis. High-quality 36-bp or paired-end 100-bp reads (for transcription factors) were aligned to the mouse (mm9) or rat (rn4) genomes using Burrows-Wheeler Aligner (BWA, v0.9.6) 34 and filtered to remove reads that mapped to multiple locations. Data from replicates were pooled, regions of enriched occupancy relative to background input were identified using MACS (v2.09) 35 with default settings, and regions with FDR < 0.05 were retained for analysis. Histone marks were called using the broad peak setting, which accounts for breaks in coverage due to repetitive sequence. All association of MACS ChIP-seq-defined regions to gene-body features (for example, gene TSS and exon and intron coordinates) was performed using coordinates downloaded from Ensembl e63 for mouse and rat. Basic genomic region manipulations, including intersections and windows, were performed using BedTools 36 . Functional annotation enrichment of genes near predicted enhancers (defined as regions of H3K27ac and H3K4me1 enrichment more than 5 kb from a gene TSS) was examined using GREAT 37 . ChIP aggregate profiles and heat maps were generated using siteproBW and heatmaprBW from the Cistrome package 38 . For heat maps, regions that fell within 5 kb of another region were discarded for visualization purposes. For comparative analysis, genomic coordinates were converted across species using the UCSC liftOver tool, requiring at least 50% of the region to be mappable (−minmatch 0.5). For each histone mark, epigenetically conserved regions were defined as regions that mapped across species and resided within 1 kb of a ChIP-seq-defined region in the other species (for example, a rat H3K4me1 region mapped to mouse overlapping or within 1 kb of a mouse H3K4me1 region). Regions of transcription factor overlap were defined as multiple transcription factor binding sites within a 1-kb window. De novo motif discovery was performed using the MDSeqPos module from Cistrome on repeat-masked sequence with the top 1,000 enriched ChIP-seq peaks for each transcription factor data set, based on MACS enrichment scores. Scanning of existing motifs was performed using FIMO, part of the MEME suite 39 , with binding motif profiles downloaded from Uniprobe 40 .
Repeat analysis. All repeat data (annotations and consensus sequences) were obtained from RepeatMasker libraries downloaded from the RepeatMasker website (see URLS; mouse, v20090604; rat, v20080521). Repeats classified as simple, satellite or unknown were discarded. Relative repeat ages were estimated on the basis of median percent sequence divergence between extant copies, which is generally indicative of actual repeat age 41 . Divergence cutoffs for species-specific and shared repeats were determined as previously described 42 . Mouse repeat ages in years were estimated using divergence/substitution rate (4.5 × 10 −9 ) 42 .
Overrepresented repeat families were identified by comparing the observed number of copies from a family overlapping a ChIP-seq data set against the background expectation. The background was estimated by generating 1,000 randomized data sets on the basis of each ChIP-seq data set, matched for region size, chromosome and relative distribution from annotated genes (an equivalent number of regions directly overlapping a gene TSS, exon, intron, 10-kb gene proximal region, 100-kb distal region or >100-kb intergenic region) to account for genomic biases in TE integration sites. The numbers of overlapping TE copies within each of the 1,000 randomized data sets were averaged to determine a background expectation, and the enrichment of the observed overlap against the background was assessed with a binomial test using Bonferroni-corrected P < 0.005. Candidate enriched repeat families were further filtered to require ≥30 observed overlaps and ≥2-fold enrichment of the observed over the expected. These additional thresholds primarily removed SINE elements, which were modestly but significantly enriched in multiple data sets. Although SINEs are likely to contribute regulatory elements as well, the extremely high frequency and small size of SINEs relative to broad regions of histone mark enrichment led us to discard them as candidates in our analysis. Further, as multiply mapping reads were discarded, our analysis was generally biased against extremely recent TE families that contain nonunique copies.
ENCODE comparison.
Illumina read data in FASTQ format for mouse ENCODE H3K4me1 ChIP-seq experiments were downloaded from the UCSC Genome Browser ENCODE portal 24 . Replicates were pooled together, remapped and processed as described.
3′ RNA-seq. Two replicates from different passages (10 million cells each) were prepared for each cell type. mRNA was extracted directly from cell lysates using Dynabeads Oligo (dT) 25 (Invitrogen) and assessed for quality using a Bioanalyzer. mRNA (500 ng) was then used to prepare 3′ RNAseq libraries as previously described 12 . Theoretically, 3′ RNA-seq ensures that only a single 3′-end fragment per mRNA transcript is represented in the data. Briefly, mRNA was heat sheared for 7 min to produce an average fragment size range of 300-500 bp and then used to generate cDNA libraries with a custom oligo(dT) primer containing Illumina-compatible adaptor sequence. cDNA fragments were end repaired and ligated to standard Illumina adaptors. Size selection was performed using E-gel SizeSelect agarose gels, and products were PCR amplified for 15 cycles and purified using AMPure XP beads. Library quality was assessed using the 2100 Bioanalyzer (Agilent) and Qubit (Invitrogen), and libraries were sequenced on the Genome Analyzer IIx.
High-quality 36-bp reads were aligned to the mouse (mm9) or rat (rn4) genomes using Bowtie 0.12.7 (ref. 43) , and reads mapping to multiple locations were removed. Significantly transcribed regions were detected using Unipeak v0.99 (J. Foley and A. Sidow, unpublished data). Regions were associated with annotated gene coordinates downloaded from Ensembl build e63, and multiple regions mapping to a single gene were combined, resulting in a raw count total of transcripts per gene. For cross-species analysis, only genes with 1:1 direct orthologs in mouse and rat (as defined by Ensembl) were retained. Read counts were normalized across samples and species using the DESeq R npg
